BreatheSuite Inc.: federal grants and contributions: 18 agreements; $5.6M value; 2 departments; 8 programs.
Assay record ASY-CA-0SZQGCN06B · Cite as: Assay Systems, “BreatheSuite Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/breathesuite-inc/
The project will integrate Advanced AI technologies in the BreatheSuite Virtual Pulmonary Rehab Program to automate patient interactions, care and management processes.
To measure the effectiveness of the BreatheSuite device on patient health outcomes and continue advancing BreatheSuite technology capabilities.
Develop and validate a data-exchange and integration prototype and value-based reporting framework with major medical payers for the Virtual Pulmonary Rehabilitation Program.
Support contract fulfillment and commercialization activities for a new medical device
Support market expansion and product development efforts to drive export revenue growth
Enhance capacity to support market expansion activities and revenue growth
Undertake market and product development activities to accelerate revenue growth
The project will target the development of a virtual COPD oriented automated exercise program facilitation and tracking tool and an internal Electronic Medical Records system.
The objective of this project is to generate a new product line of BreatheSuite Diskus and Turbuhaler device, as well as the software applications being updated to reflect the new products being implemented.
Support the commercialization activities for a new medical device
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
Engage expertise to support efforts to develop security and privacy protocols
Enhance business development capabilities to accelerate international revenue growth
This project will be focused on developing the software for a smart inhaler device.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Firmware Engineering for BreatheSuite devices.
Responsible for supporting the mechanical design and production functions at BreatheSuite.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.